NATCO PHARMA
Back to Cashflow Statement
|
NATCO PHARMA Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-16 Cr | ₹72 Cr | ₹-68 Cr | ₹9.00 Cr | ₹76 Cr |
What is the latest Net Cash Inflow / Outflow ratio of NATCO PHARMA ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹-16 Cr |
| Mar2025 | ₹72 Cr |
| Mar2024 | ₹-68 Cr |
| Mar2023 | ₹9.00 Cr |
| Mar2022 | ₹76 Cr |
How is Net Cash Inflow / Outflow of NATCO PHARMA Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹-16 Cr | Negative | |
| Mar2025 | ₹72 Cr | Positive | |
| Mar2024 | ₹-68 Cr | Negative | |
| Mar2023 | ₹9.00 Cr | -88.16 | |
| Mar2022 | ₹76 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹15,806.9 Cr | 2.7% | -0.4% | -2.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹459,497.0 Cr | 5.2% | 4.3% | 8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹294,146.0 Cr | 3.6% | 7.6% | 50.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,474.0 Cr | 3.4% | 0.7% | 32.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,349.0 Cr | 2.3% | 14% | 13.6% | Stock Analytics | |
| CIPLA | ₹113,989.0 Cr | 2% | 6% | -6.7% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | 2.7% |
-0.4% |
-2.1% |
| SENSEX | 7% |
11.5% |
-3.5% |
You may also like the below Video Courses